United Kingdom  

Sanofi pulls Zantac from U.S. and Canada after carcinogen found

Reuters Friday, 18 October 2019
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

FDA: No Carcinogens In OTC Heartburn Meds [Video]

FDA: No Carcinogens In OTC Heartburn Meds

Zantac and its generic versions, known chemically as ranitidine, are popular heartburn medicines. Reuters reports they have not been found to contain the carcinogen that ranitidine has been linked to...

Credit: Wochit News     Duration: 00:46Published

Tweets about this